{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T08:23:00Z","timestamp":1771662180767,"version":"3.50.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"PRIN","award":["Prot. 2022H77XMH"],"award-info":[{"award-number":["Prot. 2022H77XMH"]}]},{"name":"PRIN","award":["Prot. 2022H77XMH"],"award-info":[{"award-number":["Prot. 2022H77XMH"]}]},{"name":"PRIN","award":["Prot. 2022H77XMH"],"award-info":[{"award-number":["Prot. 2022H77XMH"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-06272-7","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T14:45:19Z","timestamp":1751381119000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multiomics approach provides insight into altered choline metabolism and liver injury in patients with glycogen storage disease type Ia"],"prefix":"10.1038","volume":"15","author":[{"given":"Francesca","family":"Pirozzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramin","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"Luni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Melis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Fedele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Rosano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Strisciuglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maaike H.","family":"Oosterveer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry G. J.","family":"Derks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Parenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Caterino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margherita","family":"Ruoppolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"6272_CR1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41572-023-00456-z","volume":"9","author":"WB Hannah","year":"2023","unstructured":"Hannah, W. B. et al. Glycogen storage diseases. Nat. Rev. Dis. Primers 9, 46. https:\/\/doi.org\/10.1038\/s41572-023-00456-z (2023).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"6272_CR2","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.3390\/ijms22094381","volume":"22","author":"A Molares-Vila","year":"2021","unstructured":"Molares-Vila, A., Corbal\u00e1n-Rivas, A., Carnero-Gregorio, M., Gonz\u00e1lez-Cesp\u00f3n, J. L. & Rodr\u00edguez-Cerdeira, C. Biomarkers in glycogen storage diseases: An update. Int. J. Mol. Sci. 22, 4381. https:\/\/doi.org\/10.3390\/ijms22094381 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"6272_CR3","doi-asserted-by":"publisher","first-page":"474","DOI":"10.21037\/atm.2018.10.59","volume":"6","author":"S Kanungo","year":"2018","unstructured":"Kanungo, S., Wells, K., Tribett, T. & El-Gharbawy, A. Glycogen metabolism and glycogen storage disorders. Ann. Transl. Med. 6, 474 (2018).","journal-title":"Ann. Transl. Med."},{"key":"6272_CR4","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10545-014-9772-x","volume":"38","author":"JY Chou","year":"2015","unstructured":"Chou, J. Y., Jun, H. S. & Mansfield, B. C. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase\/glucose-6-phosphate transporter complexes. J. Inherit. Metab. Dis. 38, 511\u2013519 (2015).","journal-title":"J. Inherit. Metab. Dis."},{"key":"6272_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1172-6-27","volume":"6","author":"R Froissart","year":"2011","unstructured":"Froissart, R. et al. Glucose-6-phosphatase deficiency. Orphanet. J. Rare Dis. 6, 1\u201312. https:\/\/doi.org\/10.1186\/1750-1172-6-27 (2011).","journal-title":"Orphanet. J. Rare Dis."},{"key":"6272_CR6","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.3390\/nu13113828","volume":"13","author":"TG Derks","year":"2021","unstructured":"Derks, T. G. et al. Glycogen storage disease type Ia: Current management options, burden and unmet needs. Nutrients 13, 3828. https:\/\/doi.org\/10.3390\/nu13113828 (2021).","journal-title":"Nutrients"},{"key":"6272_CR7","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3390\/metabo9120282","volume":"9","author":"F Rajas","year":"2019","unstructured":"Rajas, F., Gautier-Stein, A. & Mithieux, G. Glucose-6 phosphate, a central hub for liver carbohydrate metabolism. Metabolites 9, 282 (2019).","journal-title":"Metabolites"},{"key":"6272_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/gim.2014.128","volume":"16","author":"PS Kishnani","year":"2014","unstructured":"Kishnani, P. S. et al. Diagnosis and management of glycogen storage disease type I: A practice guideline of the American College of Medical Genetics and Genomics. Genet. Med. 16, 1 (2014).","journal-title":"Genet. Med."},{"key":"6272_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/jimd.12654","volume":"47","author":"DD Koeberl","year":"2024","unstructured":"Koeberl, D. D. et al. Gene therapy for glycogen storage diseases. J. Inherit. Metab. Dis. 47, 93\u2013118. https:\/\/doi.org\/10.1002\/jimd.12654 (2024).","journal-title":"J. Inherit. Metab. Dis."},{"key":"6272_CR10","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s11248-022-00325-7","volume":"31","author":"IO Petrova","year":"2022","unstructured":"Petrova, I. O. & Smirnikhina, S. A. Studies on glycogen storage disease type 1a animal models: A brief perspective. Transgenic Res. 31, 593\u2013606. https:\/\/doi.org\/10.1007\/s11248-022-00325-7 (2022).","journal-title":"Transgenic Res."},{"key":"6272_CR11","doi-asserted-by":"publisher","first-page":"e3612","DOI":"10.1210\/clinem\/dgac411","volume":"107","author":"A Rossi","year":"2022","unstructured":"Rossi, A. et al. A prospective study on continuous glucose monitoring in glycogen storage disease type Ia: Toward glycemic targets. J. Clin. Endocrinol. Metab. 107, e3612\u2013e3623 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"6272_CR12","doi-asserted-by":"publisher","first-page":"e3612","DOI":"10.1210\/clinem\/dgac411","volume":"107","author":"A Rossi","year":"2022","unstructured":"Rossi, A. et al. A prospective study on continuous glucose monitoring in glycogen storage disease type Ia: Toward glycemic targets. J. Clin. Endocrinol. Metab. 107, e3612\u2013e3623 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"6272_CR13","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/jimd.12267","volume":"44","author":"JH Cho","year":"2021","unstructured":"Cho, J. H., Weinstein, D. A. & Lee, Y. M. Emerging roles of autophagy in hepatic tumorigenesis and therapeutic strategies in glycogen storage disease type Ia: A review. J. Inherit. Metab. Dis. 44, 118\u2013128. https:\/\/doi.org\/10.1002\/jimd.12267 (2021).","journal-title":"J. Inherit. Metab. Dis."},{"key":"6272_CR14","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.jpeds.2014.12.015","volume":"166","author":"D Melis","year":"2015","unstructured":"Melis, D. et al. Progression of renal damage in glycogen storage disease type i is associated to hyperlipidemia: A multicenter prospective Italian study. J. Pediatr. 166, 1079\u20131082 (2015).","journal-title":"J. Pediatr."},{"key":"6272_CR15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3389\/fped.2020.00591","volume":"8","author":"B Aoun","year":"2020","unstructured":"Aoun, B. et al. Kidney and metabolic phenotypes in glycogen storage disease type-I patients. Front. Pediatr. 8, 591 (2020).","journal-title":"Front. Pediatr."},{"key":"6272_CR16","doi-asserted-by":"publisher","first-page":"100512","DOI":"10.1016\/j.jhepr.2022.100512","volume":"4","author":"MPD Haring","year":"2022","unstructured":"Haring, M. P. D. et al. High childhood serum triglyceride concentrations associate with hepatocellular adenoma development in patients with glycogen storage disease type Ia. JHEP Rep. 4, 100512 (2022).","journal-title":"JHEP Rep."},{"key":"6272_CR17","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.jpeds.2014.12.015","volume":"166","author":"D Melis","year":"2015","unstructured":"Melis, D. et al. Progression of renal damage in glycogen storage disease type I is associated to hyperlipidemia: A multicenter prospective italian study. J. Pediatr. 166, 1079\u20131082 (2015).","journal-title":"J. Pediatr."},{"key":"6272_CR18","doi-asserted-by":"publisher","first-page":"100651","DOI":"10.1016\/j.jlr.2024.100651","volume":"65","author":"A Rossi","year":"2024","unstructured":"Rossi, A. et al. A specific serum lipid signature characterizes patients with glycogen storage disease type Ia. J. Lipid. Res. 65, 100651 (2024).","journal-title":"J. Lipid. Res."},{"issue":"5","key":"6272_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/pedi.12540","volume":"18","author":"M Dambska","year":"2017","unstructured":"Dambska, M., Labrador, E. B., Kuo, C. L. & Weinstein, D. A. Prevention of complications in glycogen storage disease type Ia with optimization of metabolic control. Pediatr. Diabetes 18(5), 327\u2013331 (2017).","journal-title":"Pediatr. Diabetes"},{"key":"6272_CR20","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.3390\/jcm10204673","volume":"10","author":"L Niu","year":"2021","unstructured":"Niu, L. et al. Defining NASH from a multi-omics systems biology perspective. J. Clin. Med. 10, 4673 (2021).","journal-title":"J. Clin. Med."},{"issue":"3","key":"6272_CR21","doi-asserted-by":"publisher","first-page":"e8793","DOI":"10.15252\/msb.20188793","volume":"15","author":"L Niu","year":"2019","unstructured":"Niu, L. et al. Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease. Mol. Syst. Biol. 15(3), e8793 (2019).","journal-title":"Mol. Syst. Biol."},{"key":"6272_CR22","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s42255-023-00775-1","volume":"5","author":"O Govaere","year":"2023","unstructured":"Govaere, O. et al. A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures. Nat. Metab. 5, 572\u2013578 (2023).","journal-title":"Nat. Metab."},{"key":"6272_CR23","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/hep.1840040329","volume":"4","author":"M Asaka","year":"1984","unstructured":"Asaka, M., Miyazaki, T., Hollinger, F. B. & Alpert, E. Human aldolase B serum levels: A marker of liver injury. Hepatology 4, 531\u2013535 (1984).","journal-title":"Hepatology"},{"key":"6272_CR24","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41591-022-01850-y","volume":"28","author":"L Niu","year":"2022","unstructured":"Niu, L. et al. Noninvasive proteomic biomarkers for alcohol-related liver disease. Nat. Med. 28, 1277\u20131287 (2022).","journal-title":"Nat. Med."},{"key":"6272_CR25","doi-asserted-by":"publisher","first-page":"BSR20190395","DOI":"10.1042\/BSR20190395","volume":"40","author":"W Hou","year":"2020","unstructured":"Hou, W. et al. Proteomic screening of plasma identifies potential noninvasive biomarkers associated with significant\/advanced fibrosis in patients with nonalcoholic fatty liver disease. Biosci. Rep. 40, BSR20190395 (2020).","journal-title":"Biosci. Rep."},{"key":"6272_CR26","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/s41598-020-58030-6","volume":"10","author":"D Veyel","year":"2020","unstructured":"Veyel, D. et al. Biomarker discovery for chronic liver diseases by multi-omics\u2013a preclinical case study. Sci. Rep. 10, 1314 (2020).","journal-title":"Sci. Rep."},{"key":"6272_CR27","doi-asserted-by":"publisher","first-page":"100207","DOI":"10.1016\/j.mcpro.2022.100207","volume":"21","author":"B Stocks","year":"2022","unstructured":"Stocks, B. et al. Integrated liver and plasma proteomics in obese mice reveals complex metabolic regulation. Mol. Cell. Proteom. 21, 100207 (2022).","journal-title":"Mol. Cell. Proteom."},{"key":"6272_CR28","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1002\/hep.31198","volume":"72","author":"Y Lei","year":"2020","unstructured":"Lei, Y. et al. Hepatic carbohydrate response element binding protein activation limits nonalcoholic fatty liver disease development in a mouse model for glycogen storage disease type 1a. Hepatology 72, 1638 (2020).","journal-title":"Hepatology"},{"key":"6272_CR29","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1021\/acs.jproteome.9b00309","volume":"18","author":"D Cangelosi","year":"2019","unstructured":"Cangelosi, D. et al. A proteomic analysis of GSD-1a in mouse livers: Evidence for metabolic reprogramming, inflammation, and macrophage polarization. J. Proteome Res. 18, 2965\u20132978 (2019).","journal-title":"J. Proteome Res."},{"key":"6272_CR30","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3390\/nu9090981","volume":"9","author":"KW Ter Horst","year":"2017","unstructured":"Ter Horst, K. W. & Serlie, M. J. Fructose consumption, lipogenesis, and non-alcoholic fatty liver disease. Nutrients 9, 981. https:\/\/doi.org\/10.3390\/nu9090981 (2017).","journal-title":"Nutrients"},{"key":"6272_CR31","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s40618-022-01753-2","volume":"45","author":"PI Simons","year":"2022","unstructured":"Simons, P. I. et al. Serum sex hormone-binding globulin levels are reduced and inversely associated with intrahepatic lipid content and saturated fatty acid fraction in adult patients with glycogen storage disease type 1a. J. Endocrinol. Invest. 45, 1227\u20131234 (2022).","journal-title":"J. Endocrinol. Invest."},{"key":"6272_CR32","doi-asserted-by":"publisher","first-page":"e791","DOI":"10.1210\/clinem\/dgz244","volume":"105","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Serum SHBG is associated with the development and regression of nonalcoholic fatty liver disease: A prospective study. J. Clin. Endocrinol. Metab. 105, e791-804 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"6272_CR33","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/liv.15786","volume":"44","author":"D Kim","year":"2024","unstructured":"Kim, D., Manikat, R., Cholankeril, G. & Ahmed, A. Endogenous sex hormones and nonalcoholic fatty liver disease in <scp>US<\/scp> adults. Liver Int. 44, 460\u2013471 (2024).","journal-title":"Liver Int."},{"key":"6272_CR34","doi-asserted-by":"publisher","first-page":"113261","DOI":"10.1016\/j.biopha.2022.113261","volume":"153","author":"N Bourebaba","year":"2022","unstructured":"Bourebaba, N., Ngo, T., \u015amieszek, A., Bourebaba, L. & Marycz, K. Sex hormone binding globulin as a potential drug candidate for liver-related metabolic disorders treatment. Biomed. Pharmacother. 153, 113261 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"6272_CR35","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.tem.2015.05.001","volume":"26","author":"R Sim\u00f3","year":"2015","unstructured":"Sim\u00f3, R., S\u00e1ez-L\u00f3pez, C., Barbosa-Desongles, A., Hern\u00e1ndez, C. & Selva, D. M. Novel insights in SHBG regulation and clinical implications. Trends Endocrinol. Metab. 26, 376\u2013383 (2015).","journal-title":"Trends Endocrinol. Metab."},{"key":"6272_CR36","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s11154-024-09880-2","volume":"25","author":"A Rossi","year":"2024","unstructured":"Rossi, A. et al. Endocrine involvement in hepatic glycogen storage diseases: Pathophysiology and implications for care. Rev. Endocr. Metab. Disord. 25, 707\u2013725 (2024).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"6272_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/19396368.2017.1410591","volume":"64","author":"R Deswal","year":"2018","unstructured":"Deswal, R., Yadav, A. & Dang, A. S. Sex hormone binding globulin\u2014an important biomarker for predicting PCOS risk: A systematic review and meta-analysis. Syst. Biol. Reprod. Med. 64, 12 (2018).","journal-title":"Syst. Biol. Reprod. Med."},{"key":"6272_CR38","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.tig.2022.01.005","volume":"38","author":"C Wang","year":"2022","unstructured":"Wang, C. et al. Mendelian randomization analyses for PCOS: Evidence, opportunities, and challenges. Trends Genet. 38, 468\u2013482. https:\/\/doi.org\/10.1016\/j.tig.2022.01.005 (2022).","journal-title":"Trends Genet."},{"key":"6272_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-020-01377-w","volume":"15","author":"A Rossi","year":"2020","unstructured":"Rossi, A. et al. Imbalanced cortisol concentrations in glycogen storage disease type I: Evidence for a possible link between endocrine regulation and metabolic derangement. Orphanet. J. Rare Dis. 15, 1 (2020).","journal-title":"Orphanet. J. Rare Dis."},{"key":"6272_CR40","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3389\/fonc.2020.00847","volume":"10","author":"M Liu","year":"2020","unstructured":"Liu, M. et al. Big data-based identification of multi-gene prognostic signatures in liver cancer. Front. Oncol. 10, 847 (2020).","journal-title":"Front. Oncol."},{"key":"6272_CR41","doi-asserted-by":"publisher","first-page":"364","DOI":"10.7150\/ijms.49790","volume":"18","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Zhang, J., Chen, X. & Yang, Z. Polymeric immunoglobulin receptor (Pigr) exerts oncogenic functions via activating ribosome pathway in hepatocellular carcinoma. Int. J. Med. Sci. 18, 364 (2021).","journal-title":"Int. J. Med. Sci."},{"key":"6272_CR42","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1093\/jnci\/djr360","volume":"103","author":"J Ai","year":"2011","unstructured":"Ai, J. et al. The role of polymeric immunoglobulin receptor in inflammation-induced tumor metastasis of human hepatocellular carcinoma. J. Natl. Cancer Inst. 103, 1696 (2011).","journal-title":"J. Natl. Cancer Inst."},{"key":"6272_CR43","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41392-023-01330-w","volume":"8","author":"Q Yao","year":"2023","unstructured":"Yao, Q. et al. Osteoarthritis: Pathogenic signaling pathways and therapeutic targets. Signal Transduct. Targeted Therapy 8, 56. https:\/\/doi.org\/10.1038\/s41392-023-01330-w (2023).","journal-title":"Signal Transduct. Targeted Therapy"},{"key":"6272_CR44","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/s41419-020-03180-8","volume":"11","author":"F Dituri","year":"2020","unstructured":"Dituri, F. et al. Proteoglycan-4 is correlated with longer survival in HCC patients and enhances sorafenib and regorafenib effectiveness via CD44 in vitro. Cell Death Dis. 11, 984 (2020).","journal-title":"Cell Death Dis."},{"key":"6272_CR45","doi-asserted-by":"publisher","first-page":"9883","DOI":"10.2147\/CMAR.S269215","volume":"12","author":"L Su","year":"2020","unstructured":"Su, L., Zhang, G. & Kong, X. Prognostic significance of pregnancy zone protein and its correlation with immune infiltrates in hepatocellular carcinoma. Cancer Manag. Res. 12, 9883\u20139891 (2020).","journal-title":"Cancer Manag. Res."},{"key":"6272_CR46","doi-asserted-by":"publisher","first-page":"1282469","DOI":"10.3389\/fimmu.2023.1282469","volume":"10","author":"H Ke","year":"2023","unstructured":"Ke, H. et al. Serum protein biomarkers for HCC risk prediction in HIV\/HBV co-infected people: a clinical proteomic study using mass spectrometry. Front. Immunol. 10, 1282469 (2023).","journal-title":"Front. Immunol."},{"key":"6272_CR47","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/hep4.1487","volume":"4","author":"Y Xu","year":"2020","unstructured":"Xu, Y. et al. Hepatocyte-specific expression of human carboxylesterase 1 attenuates diet-induced steatohepatitis and hyperlipidemia in mice. Hepatol. Commun. 4, 527\u2013539 (2020).","journal-title":"Hepatol. Commun."},{"key":"6272_CR48","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1194\/jlr.M001206","volume":"51","author":"G Perdomo","year":"2010","unstructured":"Perdomo, G. et al. A role of apolipoprotein D in triglyceride metabolism. J. Lipid Res. 51, 1298\u20131311 (2010).","journal-title":"J. Lipid Res."},{"key":"6272_CR49","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/j.metabol.2011.04.013","volume":"60","author":"M Jim\u00e9nez-Palomares","year":"2011","unstructured":"Jim\u00e9nez-Palomares, M., C\u00f3zar-Castellano, I., Ganfornina, M. D., S\u00e1nchez, D. & Perdomo, G. Genetic deficiency of apolipoprotein D in the mouse is associated with nonfasting hypertriglyceridemia and hyperinsulinemia. Metabolism 60, 1767\u20131774 (2011).","journal-title":"Metabolism"},{"key":"6272_CR50","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1203\/PDR.0b013e31816c9013","volume":"63","author":"RH Bandsma","year":"2008","unstructured":"Bandsma, R. H. et al. Increased de novo lipogenesis and delayed conversion of large VLDL into intermediate density lipoprotein particles contribute to hyperlipidemia in glycogen storage disease type 1a. Pediatr. Res. 63, 702\u2013707 (2008).","journal-title":"Pediatr. Res."},{"key":"6272_CR51","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/jimd.12380","volume":"44","author":"JA Hoogerland","year":"2021","unstructured":"Hoogerland, J. A. et al. Impaired very-low-density lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in glycogen storage disease type Ia. J. Inherit. Metab. Dis. 44, 879\u2013892 (2021).","journal-title":"J. Inherit. Metab. Dis."},{"key":"6272_CR52","first-page":"100856","volume":"31","author":"A El-Gharbawy","year":"2022","unstructured":"El-Gharbawy, A. et al. Beyond predicting diagnosis: Is there a role for measuring biotinidase activity in liver glycogen storage diseases?. Mol. Genet. Metab. Rep. 31, 100856 (2022).","journal-title":"Mol. Genet. Metab. Rep."},{"key":"6272_CR53","first-page":"58","volume":"57","author":"P Forny","year":"2021","unstructured":"Forny, P., Burda, P., Bode, P. & Rohrbach, M. Is serum biotinidase enzyme activity a potential marker of perturbed glucose and lipid metabolism?. JIMD Rep. 57, 58\u201366 (2021).","journal-title":"JIMD Rep."},{"key":"6272_CR54","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s10545-018-0149-4","volume":"41","author":"A Rossi","year":"2018","unstructured":"Rossi, A. et al. Insulin-resistance in glycogen storage disease type Ia: linking carbohydrates and mitochondria?. J. Inherit. Metab. Dis. 41, 985\u2013995 (2018).","journal-title":"J. Inherit. Metab. Dis."},{"key":"6272_CR55","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.abb.2007.07.023","volume":"466","author":"P Lindblom","year":"2007","unstructured":"Lindblom, P. et al. Isoforms of alanine aminotransferases in human tissues and serum\u2014differential tissue expression using novel antibodies. Arch. Biochem. Biophys. 466, 66\u201377 (2007).","journal-title":"Arch. Biochem. Biophys."},{"key":"6272_CR56","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/jimd.12451","volume":"45","author":"T Mathis","year":"2022","unstructured":"Mathis, T. et al. Untargeted plasma metabolomics identifies broad metabolic perturbations in glycogen storage disease type I. J. Inherit. Metab. Dis. 45, 235\u2013247 (2022).","journal-title":"J. Inherit. Metab. Dis."},{"key":"6272_CR57","doi-asserted-by":"publisher","first-page":"44408","DOI":"10.1038\/srep44408","volume":"7","author":"BL Farah","year":"2017","unstructured":"Farah, B. L. et al. Hepatic mitochondrial dysfunction is a feature of Glycogen storage disease type Ia (GSDIa). Sci. Rep. 7, 44408 (2017).","journal-title":"Sci. Rep."},{"key":"6272_CR58","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/ajcn\/82.1.111","volume":"82","author":"MR Olthof","year":"2005","unstructured":"Olthof, M. R., Brink, E. J., Katan, M. B. & Verhoef, P. Choline supplemented as phosphatidylcholine decreases fasting and postmethionine-loading plasma homocysteine concentrations in healthy men. Am. J. Clin. Nutrit. 82, 111\u2013117 (2005).","journal-title":"Am. J. Clin. Nutrit."},{"key":"6272_CR59","first-page":"754","volume":"1821","author":"LK Cole","year":"2012","unstructured":"Cole, L. K., Vance, J. E. & Vance, D. E. Phosphatidylcholine biosynthesis and lipoprotein metabolism. Biochim. Biophys. Acta BBA-Mol. Cell Biol. Lipids 1821, 754\u2013761 (2012).","journal-title":"Biochim. Biophys. Acta BBA-Mol. Cell Biol. Lipids"},{"issue":"3","key":"6272_CR60","doi-asserted-by":"publisher","first-page":"380","DOI":"10.12997\/jla.2020.9.3.380","volume":"9","author":"M Taniguchi","year":"2020","unstructured":"Taniguchi, M. & Okazaki, T. Ceramide\/sphingomyelin rheostat regulated by sphingomyelin synthases and chronic diseases in murine models. J. Lipid Atherosclerosis 9(3), 380. https:\/\/doi.org\/10.12997\/jla.2020.9.3.380 (2020).","journal-title":"J. Lipid Atherosclerosis"},{"issue":"10","key":"6272_CR61","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.3390\/nu11102265","volume":"11","author":"M Inazu","year":"2019","unstructured":"Inazu, M. Functional expression of choline transporters in the blood\u2013brain barrier. Nutrients 11(10), 2265 (2019).","journal-title":"Nutrients"},{"key":"6272_CR62","doi-asserted-by":"publisher","first-page":"4318","DOI":"10.1002\/1873-3468.12461","volume":"590","author":"RJ Mailloux","year":"2016","unstructured":"Mailloux, R. J. et al. Choline and dimethylglycine produce superoxide\/hydrogen peroxide from the electron transport chain in liver mitochondria. FEBS Lett. 590, 4318\u20134328 (2016).","journal-title":"FEBS Lett."},{"key":"6272_CR63","doi-asserted-by":"publisher","first-page":"572","DOI":"10.21037\/tp-22-293","volume":"12","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Altered gut microbiota and microbial metabolism in children with hepatic glycogen storage disease: a case-control study. Transl. Pediatr. 12, 572 (2023).","journal-title":"Transl. Pediatr."},{"issue":"23","key":"6272_CR64","doi-asserted-by":"publisher","first-page":"e15127","DOI":"10.14814\/phy2.15127","volume":"9","author":"P Singh","year":"2021","unstructured":"Singh, P. et al. Overfeeding-induced weight gain elicits decreases in sex hormone-binding globulin in healthy males\u2014Implications for body fat distribution. Physiol. Rep. 9(23), e15127 (2021).","journal-title":"Physiol. Rep."},{"key":"6272_CR65","first-page":"3277","volume":"83","author":"J Pritchard","year":"1998","unstructured":"Pritchard, J. et al. Plasma adrenal, gonadal, and conjugated steroids before and after long term overfeeding in identical twins. J. Clin. Endocrinol. Metab. 83, 3277\u20133284 (1998).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"6272_CR66","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.clinbiochem.2018.08.002","volume":"60","author":"AM Wiedeman","year":"2018","unstructured":"Wiedeman, A. M. et al. Variations in plasma choline and metabolite concentrations in healthy adults. Clin. Biochem. 60, 77 (2018).","journal-title":"Clin. Biochem."},{"key":"6272_CR67","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.3390\/nu14051093","volume":"14","author":"M Videja","year":"2022","unstructured":"Videja, M. et al. Fasting-mimicking diet reduces trimethylamine N-oxide levels and improves serum biochemical parameters in healthy volunteers. Nutrients 14, 1093 (2022).","journal-title":"Nutrients"},{"key":"6272_CR68","doi-asserted-by":"publisher","first-page":"9548","DOI":"10.3390\/ijms22179548","volume":"22","author":"M Caterino","year":"2021","unstructured":"Caterino, M. et al. The serum metabolome of moderate and severe covid-19 patients reflects possible liver alterations involving carbon and nitrogen metabolism. Int. J. Mol. Sci. 22, 9548 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"6272_CR69","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1038\/s41598-021-82426-7","volume":"11","author":"M Caterino","year":"2021","unstructured":"Caterino, M. et al. Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19. Sci. Rep. 11, 2941 (2021).","journal-title":"Sci. Rep."},{"key":"6272_CR70","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.compbiolchem.2008.07.019","volume":"33","author":"K Vanden Branden","year":"2009","unstructured":"Vanden Branden, K. & Verboven, S. Robust data imputation. Comput. Biol. Chem. 33, 7\u201313 (2009).","journal-title":"Comput. Biol. Chem."},{"key":"6272_CR71","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1073\/pnas.091062498","volume":"98","author":"VG Tusher","year":"2001","unstructured":"Tusher, V. G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. 98, 5116\u20135121 (2001).","journal-title":"Proc. Natl. Acad. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06272-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06272-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06272-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T10:29:42Z","timestamp":1751624982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06272-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6272"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-06272-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20658"}}